OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells is a paramount challenge for the biopharmaceutical industry. A variety of strategies have been employed enhance antibody titer, comprising process parameter optimization, media optimization, and implementation of perfusion processes. Fine-tuning growth para